课题基金 / 基金详情

Huntsman Cancer Institute PathMaker Programs for Cancer Research

Huntsman Cancer Institute PathMaker Programs for Cancer Research
亨斯迈癌症研究所癌症研究 PathMaker 计划
批准号:
10005296
负责人:
Donald E Ayer
金额:
$54.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-09-01 至 2025-07-31

项目摘要

项目成果

Donald E Ayer的其他基金

相似基金

相关文献

中文摘要
翻译
这个R25应用程序的首要目标是增强来自 有兴趣从事生物医学和癌症相关研究的代表不足的群体 为高中生和本科生提供研究经验、研究和课程 初中和高中理科教师的发展经验,并延伸到中学 学生、他们的家庭和他们的社区。亨斯迈癌症研究所的路径制定者计划 癌症研究公司将为犹他州和山区带来特殊的癌症研究培训流水线计划 WEST支持国家癌症研究所的R25计划目标,即增加生物医学的多样性, 行为和临床研究人员。拟议的计划,建立在成功的P30治愈和 FRTEP补充剂将包括三个相互关联和相辅相成的组成部分:帕特梅克学者, 路径生成器桥和路径生成器连接。Path Maker Scholars是一次有指导的癌症研究经历 为高中生和本科生提供癌症研究指导 为初中和高中科学教师提供经验和指导课程开发,提供 连接到他们的学生;通过PathMaker Connect,我们将连接HCI和前面提到的两个 通过一项创新的外展活动,将群体推广到特定的社区。而来自所有群体的申请者 将鼓励和欢迎在生物医学研究中代表性不足的人,招聘努力将集中在 学生属于对犹他州和盐湖城有重要意义的三个少数民族之一:西班牙裔/拉丁裔, 美洲印第安人或阿拉斯加原住民,或夏威夷原住民或太平洋岛民。西班牙裔/拉丁裔构成犹他州 最大的少数民族人口,占总人口的14%,占18岁以下人口的近18% 年纪大了。此外,犹他州有八个美洲印第安人部落或民族,还有一个令人惊讶的大太平洋岛民 人口,包括汤加所有美国人的四分之一。这些群体在中国的代表性严重不足 生物医学研究,他们面临着与癌症相关的巨大健康差距。这个项目将由一位 由一名内科科学家和一名基础科学家组成的团队,他们在以下项目中具有相关经验 增加生物医学研究职业、职业指导和生物医学研究职业培训的多样性。 学生的研究经验将通过丰富的专业准备和社区建设而得到加强 程序。此外,帕特梅克·布里奇将与国际公认的犹他大学合作 基因科学学习中心(GSLC)提供卓越的职业发展计划,以 指导教师参与者利用他们的研究经验创建新的课程材料, 在全球可持续发展委员会网站上进行全球传播的可能性。专业的评估师将提供形成性的 和终结性评估,以确保计划发挥其最大潜力。
英文摘要
The overarching goal of this R25 application is to enhance the diversity of the pool of individuals from underrepresented groups interested in pursuing careers in biomedical and cancer-related research by providing research experiences for high school and undergraduate students, research and curriculum development experiences for middle and high school science teachers, and outreach to middle school students, their families, and their communities. The Huntsman Cancer Institute PathMaker Programs for Cancer Research will bring exceptional cancer research training pipeline programs to Utah and the Mountain West to support the National Cancer Institute’s R25 program goal of increasing diversity of the biomedical, behavioral, and clinical research workforce. The proposed program, building on successful P30 CURE and FRTEP Supplements, will comprise three interrelated and complementary components: PathMaker Scholars, PathMaker Bridge, and PathMaker Connect. PathMaker Scholars is a mentored cancer research experience for high school and undergraduate students; PathMaker Bridge provides mentored cancer research experiences and guided curriculum development for middle and high school science teachers, providing a bridge to their students; with PathMaker Connect we will connect HCI and the two previously-mentioned groups to a specific community through an innovative outreach event. While applicants from all groups underrepresented in biomedical research will be encouraged and welcomed, recruiting efforts will focus on students who belong to one of three minority groups significant to Utah and Salt Lake City: Hispanic/Latino, American Indian or Alaska Native, or Native Hawaiian or Pacific Islander. Hispanic/Latinos comprise Utah’s largest minority population, with 14% of the overall population and nearly 18% of the population under 18 years of age. Also, Utah is home to eight American Indian tribes or nations, and a surprisingly large Pacific Islander population including one-fourth of all Tongan Americans. These groups are massively underrepresented in biomedical research, and they face significant cancer-related health disparities. This project will be led by a team comprising a physician scientist and a basic scientist, who have relevant experience in programs to increase diversity in biomedical research careers, career mentoring, and biomedical research career training. Student research experiences will be enhanced by a rich professional preparation and community-building program. Additionally, PathMaker Bridge will partner with the internationally-recognized University of Utah Genetic Science Learning Center (GSLC) to provide an exceptional professional development program to guide teacher participants in using their research experiences to create novel curricular materials, with the potential for world-wide dissemination on the GSLC website. A professional evaluator will provide formative and summative evaluation to ensure the program achieves its maximum potential.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Huntsman Cancer Institute (HCI) Cancer Genetics, Epigenetics, Models, and Signaling (Cancer GEMS) Training Program
  • 批准号:
    10627604
  • 项目类别:
  • 资助金额:
    $19.69万
  • 财政年份:
    2023
  • 负责人:
    Donald E Ayer
  • 依托单位:
Huntsman Cancer Institute PathMaker Programs for Cancer Research
  • 批准号:
    10474257
  • 项目类别:
  • 资助金额:
    $54.0万
  • 财政年份:
    2019
  • 负责人:
    Donald E Ayer
  • 依托单位:
Huntsman Cancer Institute PathMaker Programs for Cancer Research
  • 批准号:
    10661674
  • 项目类别:
  • 资助金额:
    $53.93万
  • 财政年份:
    2019
  • 负责人:
    Donald E Ayer
  • 依托单位:
Huntsman Cancer Institute PathMaker Programs for Cancer Research
  • 批准号:
    9792209
  • 项目类别:
  • 资助金额:
    $42.03万
  • 财政年份:
    2019
  • 负责人:
    Donald E Ayer
  • 依托单位:
海外基金